G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
04 02 2021
Historique:
received: 01 04 2020
revised: 03 11 2020
accepted: 14 12 2020
pubmed: 27 1 2021
medline: 25 8 2021
entrez: 26 1 2021
Statut: ppublish

Résumé

Ras GTPase-activating protein-binding proteins 1 and 2 (G3BP1 and G3BP2, respectively) are widely recognized as core components of stress granules (SGs). We report that G3BPs reside at the cytoplasmic surface of lysosomes. They act in a non-redundant manner to anchor the tuberous sclerosis complex (TSC) protein complex to lysosomes and suppress activation of the metabolic master regulator mechanistic target of rapamycin complex 1 (mTORC1) by amino acids and insulin. Like the TSC complex, G3BP1 deficiency elicits phenotypes related to mTORC1 hyperactivity. In the context of tumors, low G3BP1 levels enhance mTORC1-driven breast cancer cell motility and correlate with adverse outcomes in patients. Furthermore, G3bp1 inhibition in zebrafish disturbs neuronal development and function, leading to white matter heterotopia and neuronal hyperactivity. Thus, G3BPs are not only core components of SGs but also a key element of lysosomal TSC-mTORC1 signaling.

Identifiants

pubmed: 33497611
pii: S0092-8674(20)31694-9
doi: 10.1016/j.cell.2020.12.024
pmc: PMC7868890
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
G3BP2 protein, human 0
Insulin 0
Lysosomal Membrane Proteins 0
Poly-ADP-Ribose Binding Proteins 0
RNA Recognition Motif Proteins 0
RNA-Binding Proteins 0
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
DNA Helicases EC 3.6.4.-
G3BP1 protein, human EC 3.6.4.12
RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

655-674.e27

Subventions

Organisme : Medical Research Council
ID : MC_PC_16035
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Cell. 2017 Oct 19;171(3):642-654.e12
pubmed: 29053970
Life Sci Alliance. 2019 Mar 28;2(2):
pubmed: 30923191
Am J Respir Cell Mol Biol. 2006 Apr;34(4):473-80
pubmed: 16388022
Int J Mol Sci. 2018 Mar 16;19(3):
pubmed: 29547541
Hum Mutat. 2014 Apr;35(4):447-51
pubmed: 24515783
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
J Cell Biol. 2003 Mar 17;160(6):823-31
pubmed: 12642610
Nat Commun. 2016 Feb 12;7:10662
pubmed: 26868506
PLoS Genet. 2014 Nov 06;10(11):e1004763
pubmed: 25375155
Mol Cell Biol. 1996 Jun;16(6):2561-9
pubmed: 8649363
Neurosci Lett. 1996 Sep 27;216(2):109-12
pubmed: 8904795
Semin Cell Dev Biol. 2016 Apr;52:12-20
pubmed: 26849906
J Cell Sci. 2020 Sep 1;133(16):
pubmed: 32873715
Int J Mol Sci. 2018 May 22;19(5):
pubmed: 29789464
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):409-14
pubmed: 24367102
Cancer Discov. 2014 May;4(5):546-53
pubmed: 24625776
PLoS One. 2015 May 12;10(5):e0125898
pubmed: 25965391
Cell. 2006 Sep 8;126(5):955-68
pubmed: 16959574
Neurobiol Dis. 2017 Dec;108:225-237
pubmed: 28888969
Oncotarget. 2015 Jul 10;6(19):17039-53
pubmed: 25962958
Cell. 2014 Feb 13;156(4):786-99
pubmed: 24529380
J Drug Target. 2019 Mar;27(3):300-305
pubmed: 30207743
Neuroscience. 2017 Jan 26;341:112-153
pubmed: 27889578
Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):360-370
pubmed: 30595162
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Oncotarget. 2016 Aug 2;7(31):49322-49333
pubmed: 27384994
Oncogene. 2003 Jul 31;22(31):4786-98
pubmed: 12894220
Dev Cell. 2020 Nov 9;55(3):272-288.e5
pubmed: 32898476
Curr Biol. 2005 Apr 26;15(8):702-13
pubmed: 15854902
Elife. 2016 Jan 07;5:
pubmed: 26742086
J Virol. 2015 Mar;89(5):2575-89
pubmed: 25520508
Zebrafish. 2015 Oct;12(5):349-56
pubmed: 26355474
PLoS One. 2007 Nov 21;2(11):e1217
pubmed: 18030348
Oncogene. 2002 Dec 5;21(55):8470-6
pubmed: 12466966
Curr Biol. 2010 Apr 27;20(8):R371-81
pubmed: 21749961
Biophys J. 2018 Dec 4;115(11):2081-2086
pubmed: 30447995
Cell. 2001 May 4;105(3):345-55
pubmed: 11348591
Nat Rev Cancer. 2018 Dec;18(12):744-757
pubmed: 30425336
Nat Cell Biol. 2019 Jan;21(1):63-71
pubmed: 30602761
Mol Cytogenet. 2017 Jul 20;10:27
pubmed: 28736577
Mol Aspects Med. 2006 Oct-Dec;27(5-6):495-502
pubmed: 16973206
Neuropathol Appl Neurobiol. 2018 Feb;44(1):6-17
pubmed: 29359340
Mol Cell Proteomics. 2015 Aug;14(8):2042-55
pubmed: 25907765
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Cell Death Differ. 2018 Nov;25(10):1766-1780
pubmed: 29523872
Biochem Biophys Res Commun. 1997 Sep 8;238(1):207-12
pubmed: 9299480
Mol Cell Biol. 2004 Apr;24(8):3112-24
pubmed: 15060135
J Cell Biochem. 2001;84(1):173-87
pubmed: 11746526
Cancer Cell. 2006 Sep;10(3):215-26
pubmed: 16959613
Neuromolecular Med. 2006;8(4):531-46
pubmed: 17028374
Curr Biol. 2003 Aug 5;13(15):1259-68
pubmed: 12906785
Nat Rev Mol Cell Biol. 2020 Apr;21(4):183-203
pubmed: 31937935
Genes Dev. 2001 Jun 1;15(11):1383-92
pubmed: 11390358
J Neurosci. 2012 Feb 1;32(5):1771-83
pubmed: 22302816
Cell. 2001 May 4;105(3):357-68
pubmed: 11348592
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Biol Chem. 2000 Nov 17;275(46):36441-9
pubmed: 10969074
Biochem Pharmacol. 2019 Apr;162:123-131
pubmed: 30326201
J Neurochem. 2013 Apr;125(2):175-84
pubmed: 23373770
Oncogene. 2006 Oct 16;25(48):6361-72
pubmed: 17041622
Breast Cancer Res Treat. 2010 Oct;123(3):725-31
pubmed: 20020197
Nat Commun. 2013;4:2410
pubmed: 24002024
Cell Host Microbe. 2007 Nov 15;2(5):295-305
pubmed: 18005751
Structure. 2013 Sep 3;21(9):1492-9
pubmed: 24010708
J Med Genet. 2013 Nov;50(11):740-4
pubmed: 23687350
J Biol Chem. 2002 Sep 20;277(38):35402-10
pubmed: 12140284
Nat Methods. 2013 May;10(5):413-20
pubmed: 23524393
Neuropharmacology. 2020 Apr;166:107908
pubmed: 31962286
Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2170-2179
pubmed: 31932427
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
Front Neural Circuits. 2013 Apr 08;7:63
pubmed: 23580329
J Neurosci Methods. 2017 Aug 01;287:13-24
pubmed: 28577986
J Anat. 2019 Sep;235(3):521-542
pubmed: 30901081
Mol Cell Biol. 2005 Oct;25(19):8703-16
pubmed: 16166649
Mol Cell Biol. 2008 Jun;28(12):4104-15
pubmed: 18411301
PLoS One. 2013 Nov 14;8(11):e79765
pubmed: 24244558
Mol Cell. 2012 Aug 24;47(4):535-46
pubmed: 22795129
Cell. 2014 Feb 13;156(4):771-85
pubmed: 24529379
Biotechniques. 2009 Apr;46(4):265-74
pubmed: 19450233
Genes Cells. 2013 Feb;18(2):135-46
pubmed: 23279204
J Cell Biol. 2013 Nov 25;203(4):563-74
pubmed: 24385483
Cell. 2013 Aug 15;154(4):859-74
pubmed: 23953116
J Cell Sci. 2013 Nov 15;126(Pt 22):5166-77
pubmed: 24013546
Cold Spring Harb Perspect Med. 2015 Apr 01;5(4):
pubmed: 25833943
J Cell Sci. 2011 Jul 1;124(Pt 13):2310-20
pubmed: 21652632
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Int J Dev Biol. 2004 Dec;48(10):1065-77
pubmed: 15602692
Cell. 2020 Apr 16;181(2):346-361.e17
pubmed: 32302572
Int J Mol Sci. 2018 Mar 12;19(3):
pubmed: 29534520
J Biol Chem. 2019 Feb 22;294(8):2970-2975
pubmed: 30651352
J Cell Biol. 2016 Mar 28;212(7):845-60
pubmed: 27022092
Structure. 2020 Aug 4;28(8):933-942.e4
pubmed: 32502382
J Biol Chem. 2005 Jul 15;280(28):26089-93
pubmed: 15905173
Am J Hum Genet. 2014 Oct 2;95(4):360-70
pubmed: 25262651
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
J Biol Chem. 1999 Dec 10;274(50):35647-52
pubmed: 10585443
Biochim Biophys Acta. 2015 Jul;1849(7):861-70
pubmed: 25482014
Mol Cell. 2003 Jun;11(6):1457-66
pubmed: 12820960
Nat Cell Biol. 2013 Oct;15(10):1186-96
pubmed: 23955302
Nat Rev Neurol. 2016 Jul;12(7):379-92
pubmed: 27340022
Dev Cell. 2015 Mar 9;32(5):617-30
pubmed: 25727005
Am J Cancer Res. 2016 Nov 01;6(11):2641-2650
pubmed: 27904777
Biosens Bioelectron. 2009 Sep 15;25(1):234-9
pubmed: 19596565
Genes Dev. 2003 Aug 1;17(15):1829-34
pubmed: 12869586
PLoS One. 2011;6(12):e29024
pubmed: 22205990
Eur J Neurosci. 2018 Mar;47(6):534-548
pubmed: 28452083
Nucleic Acids Res. 2015 Feb 27;43(4):e26
pubmed: 25488811
Biochem J. 2008 Jun 1;412(2):179-90
pubmed: 18466115
J Cell Sci. 2002 Aug 15;115(Pt 16):3227-34
pubmed: 12140254
Sci Rep. 2019 Sep 9;9(1):12896
pubmed: 31501480
J Cell Biol. 2019 Jul 1;218(7):2425-2432
pubmed: 31171631
Cell Death Dis. 2018 May 2;9(5):501
pubmed: 29717134
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15957-15966
pubmed: 31341085
Expert Rev Neurother. 2008 Mar;8(3):457-67
pubmed: 18345974
Dis Model Mech. 2011 Mar;4(2):255-67
pubmed: 20959633
Cells. 2019 Oct 04;8(10):
pubmed: 31590334
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Methods Enzymol. 2007;431:61-81
pubmed: 17923231
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Int J Dermatol. 2011 Jan;50(1):13-20
pubmed: 21182496
Cell. 2013 Feb 14;152(4):791-805
pubmed: 23415227
Ann N Y Acad Sci. 2010 Jan;1184:87-105
pubmed: 20146692
Nat Rev Cancer. 2020 Feb;20(2):74-88
pubmed: 31686003
Nat Cell Biol. 2003 Jun;5(6):578-81
pubmed: 12771962
Nat Commun. 2019 Feb 12;10(1):708
pubmed: 30755616
Cancer Discov. 2014 May;4(5):554-63
pubmed: 24631838
Mol Cell. 2002 Apr;9(4):789-98
pubmed: 11983170
Nat Commun. 2019 Apr 23;10(1):1917
pubmed: 31015467
Mol Cancer. 2013 Dec 09;12(1):156
pubmed: 24321297
J Cell Sci. 2019 Nov 13;132(21):
pubmed: 31722960
Mol Cell Biol. 1998 Jul;18(7):3956-65
pubmed: 9632780
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Clin Cancer Res. 2012 Mar 15;18(6):1777-89
pubmed: 22422409
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Cell. 2020 Apr 16;181(2):325-345.e28
pubmed: 32302571
Cell. 2005 Apr 22;121(2):179-93
pubmed: 15851026
Cancer Sci. 2012 Oct;103(10):1848-56
pubmed: 22703643
ACS Chem Neurosci. 2016 May 18;7(5):588-98
pubmed: 26822114
EBioMedicine. 2014 Dec 26;2(1):2-4
pubmed: 26137524
Nat Commun. 2020 Oct 5;11(1):4979
pubmed: 33020468
Cell. 2019 Sep 19;179(1):147-164.e20
pubmed: 31539493
Hum Mol Genet. 1998 Jun;7(6):1053-7
pubmed: 9580671
J Biol Chem. 2011 Sep 9;286(36):31501-11
pubmed: 21757713

Auteurs

Mirja Tamara Prentzell (MT)

Brain Cancer Metabolism Group, German Consortium of Translational Cancer Research (DKTK) & German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Department of Pediatrics, Section Systems Medicine of Metabolism and Signaling, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, The Netherlands; Department of Bioinformatics and Molecular Genetics (Faculty of Biology), University of Freiburg, Freiburg 79104, Germany; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg 79104, Germany.

Ulrike Rehbein (U)

Department of Pediatrics, Section Systems Medicine of Metabolism and Signaling, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, The Netherlands; Department for Neuroscience, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg 26129, Germany; Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria.

Marti Cadena Sandoval (M)

Department of Pediatrics, Section Systems Medicine of Metabolism and Signaling, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, The Netherlands; Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria.

Ann-Sofie De Meulemeester (AS)

Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven BE-3000, Belgium.

Ralf Baumeister (R)

Department of Bioinformatics and Molecular Genetics (Faculty of Biology), University of Freiburg, Freiburg 79104, Germany; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg 79104, Germany; Signalling Research Centres BIOSS and CIBSS & ZBMZ Center for Biochemistry and Molecular Cell Research (Faculty of Medicine), University of Freiburg, Freiburg 79104, Germany.

Laura Brohée (L)

Cell Growth Control in Health and Age-Related Disease Group, Max Planck Institute for Biology of Ageing (MPI-AGE), Cologne 50931, Germany.

Bianca Berdel (B)

Brain Cancer Metabolism Group, German Consortium of Translational Cancer Research (DKTK) & German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Mathias Bockwoldt (M)

Department of Arctic and Marine Biology, UiT The Arctic University of Norway, Tromsø 9037, Norway.

Bernadette Carroll (B)

School of Biochemistry, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.

Suvagata Roy Chowdhury (SR)

Cell Signaling and Metabolism Group, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Andreas von Deimling (A)

German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Department of Neuropathology, Institute of Pathology, Heidelberg University, Heidelberg 69120, Germany.

Constantinos Demetriades (C)

Cell Growth Control in Health and Age-Related Disease Group, Max Planck Institute for Biology of Ageing (MPI-AGE), Cologne 50931, Germany; CECAD Cluster of Excellence, University of Cologne, Cologne 50931, Germany.

Gianluca Figlia (G)

Signal Transduction in Cancer and Metabolism, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Heidelberg University, Heidelberg 69120, Germany.

Mariana Eca Guimaraes de Araujo (MEG)

Institute of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria.

Alexander M Heberle (AM)

Department of Pediatrics, Section Systems Medicine of Metabolism and Signaling, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, The Netherlands; Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria.

Ines Heiland (I)

Department of Arctic and Marine Biology, UiT The Arctic University of Norway, Tromsø 9037, Norway.

Birgit Holzwarth (B)

Department of Bioinformatics and Molecular Genetics (Faculty of Biology), University of Freiburg, Freiburg 79104, Germany.

Lukas A Huber (LA)

Institute of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria; Austrian Drug Screening Institute (ADSI), Innsbruck 6020, Austria.

Jacek Jaworski (J)

Laboratory of Molecular and Cellular Neurobiology, International Institute of Molecular and Cell Biology in Warsaw, Warsaw 02-109, Poland.

Magdalena Kedra (M)

Laboratory of Molecular and Cellular Neurobiology, International Institute of Molecular and Cell Biology in Warsaw, Warsaw 02-109, Poland.

Katharina Kern (K)

Brain Cancer Metabolism Group, German Consortium of Translational Cancer Research (DKTK) & German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Andrii Kopach (A)

Laboratory of Molecular and Cellular Neurobiology, International Institute of Molecular and Cell Biology in Warsaw, Warsaw 02-109, Poland.

Viktor I Korolchuk (VI)

Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Ineke van 't Land-Kuper (I)

Department of Pediatrics, Section Systems Medicine of Metabolism and Signaling, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, The Netherlands; Department for Neuroscience, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg 26129, Germany.

Matylda Macias (M)

Laboratory of Molecular and Cellular Neurobiology, International Institute of Molecular and Cell Biology in Warsaw, Warsaw 02-109, Poland.

Mark Nellist (M)

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam 3015 GD, The Netherlands.

Wilhelm Palm (W)

Cell Signaling and Metabolism Group, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Stefan Pusch (S)

German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Department of Neuropathology, Institute of Pathology, Heidelberg University, Heidelberg 69120, Germany.

Jose Miguel Ramos Pittol (JM)

Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria.

Michèle Reil (M)

Brain Cancer Metabolism Group, German Consortium of Translational Cancer Research (DKTK) & German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Anja Reintjes (A)

Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria.

Friederike Reuter (F)

Brain Cancer Metabolism Group, German Consortium of Translational Cancer Research (DKTK) & German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Julian R Sampson (JR)

Institute of Medical Genetics, Division of Cancer and Genetics, Cardiff University Medical School, Cardiff CF14 4AY, UK.

Chloë Scheldeman (C)

Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven BE-3000, Belgium; Neurogenetics Research Group, VUB, Brussels 1090, Belgium.

Aleksandra Siekierska (A)

Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven BE-3000, Belgium.

Eduard Stefan (E)

Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria.

Aurelio A Teleman (AA)

Signal Transduction in Cancer and Metabolism, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Heidelberg University, Heidelberg 69120, Germany.

Laura E Thomas (LE)

Institute of Life Science, Swansea University, Swansea SA2 8PP, UK.

Omar Torres-Quesada (O)

Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria.

Saskia Trump (S)

Molecular Epidemiology Unit, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin 13353, Germany.

Hannah D West (HD)

Institute of Medical Genetics, Division of Cancer and Genetics, Cardiff University Medical School, Cardiff CF14 4AY, UK.

Peter de Witte (P)

Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven BE-3000, Belgium.

Sandra Woltering (S)

Brain Cancer Metabolism Group, German Consortium of Translational Cancer Research (DKTK) & German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.

Teodor E Yordanov (TE)

Institute of Cell Biology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria; Division of Cell and Developmental Biology, Institute for Molecular Bioscience, University of Queensland, St Lucia QLD 4072, Australia.

Justyna Zmorzynska (J)

Laboratory of Molecular and Cellular Neurobiology, International Institute of Molecular and Cell Biology in Warsaw, Warsaw 02-109, Poland.

Christiane A Opitz (CA)

Brain Cancer Metabolism Group, German Consortium of Translational Cancer Research (DKTK) & German Cancer Research Center (DKFZ), Heidelberg 69120, Germany; Department of Neurology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg 69120, Germany. Electronic address: c.opitz@dkfz.de.

Kathrin Thedieck (K)

Department of Pediatrics, Section Systems Medicine of Metabolism and Signaling, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, The Netherlands; Department for Neuroscience, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg 26129, Germany; Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck 6020, Austria. Electronic address: kathrin.thedieck@uibk.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH